Aging Mind Foundation

The FDA has approved Crexont, a new extended-release oral medication developed by Amneal Pharmaceuticals, designed to improve symptom control with fewer doses. This breakthrough promises more "on" time and a better quality of life for Parkinson's patients.

Alzheimer's vs. Dementia 🧠💡
Alzheimer's is a specific type of dementia, characterized by memory loss and cognitive decline. Dementia, on the other hand, is an umbrella term for a range of symptoms affecting memory, thinking, and social abilities. Understanding these distinctions is crucial in raising awareness and supporting those affected.